Bariatric Surgery Devices Market to grow at 9.5% CAGR to 2023 | By Key Vendors: APOLLO ENDOSURGERY, ETHICON, TRANSENTERIX, ALLERGAN, JOHNSON & JOHNSON, RESHAPE MEDICAL

The global bariatric surgery devices market is expected to register a CAGR of 9.5% during the forecast period, 2018 to 2023. Bariatric surgery is mainly used to reduce body weight. Bariatric surgical procedures are carried out for the treatment of a comorbid condition, which is associated with morbid obesity requires bariatric surgery devices.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16988
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Increase in Obese Population
According to World Health Organisation (WHO), in 2016, more than 1.9 billion adults, 18 years and older, were overweight; of these over 650 million were obese. This means that about one-third of the overall global population is overweight; this is fueled by urbanization, poor diets, and lack of physical activity. Among all the countries, the United States has the large percentage of obese children and young adults, around 13%. As the prevalence of obesity is increasing worldwide, the overall bariatric surgeries are expected to increase, which will directly propel the bariatric surgery devices market. The other factors, such as the prevalence of diabetes, insurance coverage for the surgeries, and government initiatives, are driving the market.

Key Developments in the Market
• November 2017: Apollo Endosurgery received FDA Clearance for OverStitch Sx Endoscopic Suturing System.
• August 2017: As per FDA, five deaths were reported while using weight loss balloon treatment.

Major Players:
APOLLO ENDOSURGERY INC., ETHICON INC., TRANSENTERIX INC., ALLERGAN, INC., JOHNSON & JOHNSON, RESHAPE MEDICAL, INC., COVIDIEN PLC, ENTEROMEDICS, INC., AND ASPIRE BARIATRICS INC., amongst others.

Get Quality Discount @ https://marketprognosis.com/discount-request/16988
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

High Cost of Surgery
The high cost of the surgery is due to pre- and post-surgery fees. Cost depends on the surgery type, which may range between USD 15,000-35,000. The most expensive among the surgeries is the duodenal switch surgery, which costs about USD 27,000. The gastric sleeve surgery, which is highly recommended, costs about USD 19,000. Insurance companies cover only a portion of these expenses. The huge cost associated with the surgeries will restrain the growth of the market. Along with these, other factors, such as lack of awareness in developing countries and lower disposable incomes in developing countries, are hindering the growth of the market for bariatric surgery devices.

North America to Dominate the Market
North America dominates the market for bariatric surgery devices as the people in the region have higher disposable incomes when compared to other regions, especially as these bariatric surgery procedures are expensive. In terms of revenue, the European bariatric surgery market follows that of North America.

Browse Report @ https://marketprognosis.com/enquiry/16988
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.